Coronavirus digest: J&J requests EU vaccine authorization
Published
Johnson & Johnson is the fourth drugmaker to seek approval of its COVID-19 vaccine in the European Union. The European Medicines Agency said it could decide by "the middle of March," provided it had enough data.
Full Article